Factual data · GO/NO-GO verdict · Financial model calibrated over 96 months
In Copenhagen, pharmacy valuation is 80-110 % of revenue (90 % average), with a regulated gross margin of 26-32 %. New creation is extremely rare (transfer/merger only).
Dominant profile: business · capitale
Copenhagen (Capital Region, Denmark) has about 660K inhabitants and shows dense business fabric (HQs, B2B services, professionals), and capital-city status (administration, embassies, official events) smoothing off-season demand. For a pharmacy project, this means a high average ticket and a setup cost above national by 50 %.
Local purchasing power and lead density allow targeting the high end of the revenue range from year 2. Concretely, initial investment calibrated for Copenhagen ranges from 1.2M DKK to 5.3M DKK, and Year 1 target revenue sits between 2.2M DKK and 6.5M DKK — a range that already factors in the local coefficients of this city (+50% vs average on costs, +45% vs average on purchasing power).
Competitive density: high (dense supply, segmentation required).
Dominant players: regulated public-insurance sector, few private chains.
Positioning recommendation: Competitive positioning required: sector margin is tight, edge comes from operational efficiency.
| Indicator | Year 1 | Year 2 | Year 3 |
|---|---|---|---|
| Year 1 revenue | 2.2M DKK → 6.5M DKK | ×1,18 (ramp-up) | ×1,32 (steady-state) |
| Target net margin | negative to low | 4 % | 10 % |
| Working capital (days of revenue) | 45-60 d | 35-50 d | 30-45 d |
| Cumulative ROI | investment | ~50 % | Payback at 96 months |
These ratios are calibrated on MarketLens sector benchmarks and adjusted by local coefficients of Copenhagen, Denmark (cost +50% vs average, income +45% vs average).
This page combines multiple data sources for a factual analysis calibrated on Copenhagen.
MarketLens combines AI market study, business plan calibrated for 24 countries, and post-launch monitoring. Everything exportable to PDF, PowerPoint, Excel and Word.